Patients with mild ischemic stroke did not benefit from treatment with the clot busting agent alteplase at 90 days compared to aspirin (325 mg) alone according to the PRISMS Trial phase IIb.
JAMA. 2018 Jul 10;320(20):156-166
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment